Requalification of Single Lot of S66 Reference Standard
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Health and Human Services (HHS) has issued a Notice of Intent (NOI) to award a sole source, firm fixed-price contract to Millipore Sigma. This contract is for the requalification of a single lot of S66 reference standard of PEN-866. The purpose is to ensure data continuity, traceability, and regulatory compliance. Interested parties must submit capability statements demonstrating competitive advantage by May 8, 2026.
Scope of Work
The requirement involves a retesting program to requalify a single lot of S66 reference standard of PEN-866. This process will generate a certificate of testing for the standard and provide it to POB. The requalification is critical to preserve data continuity, traceability, and regulatory compliance for the instrument.
Contract & Timeline
- Type: Notice of Intent to Award Sole Source (Firm Fixed-Price)
- Intended Awardee: Millipore Sigma
- Authority: FAR subpart 13.106-1(b)(1)(i) (purchases not exceeding the Simplified Acquisition Threshold where only one source is reasonably available)
- NAICS: 541380, Testing Laboratories
- PSC: AN42, Health R&D Services; Health Care-Other; Applied Research
- Set-Aside: None (Sole Source)
- Response Due: May 8, 2026, 4:00 PM ET (within five calendar days of publication)
- Published: May 6, 2026
Additional Notes
This synopsis is not a solicitation. Responses are solely for determining if a competitive procurement is advantageous to the Government. Any response must provide clear and convincing evidence of competitive advantage. Information received will be considered for market research purposes only. No reimbursement will be provided for submitting capability information. Capability statements must be submitted via email to Shannon.scarboro@hhs.gov.